Kimer N - Search Results

1

Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites-Is it safe?

Gluud LL, Kimer N, Møller S. Gluud LL, et al. Among authors: kimer n. Aliment Pharmacol Ther. 2022 Sep;56(5):909-910. doi: 10.1111/apt.17099. Aliment Pharmacol Ther. 2022. PMID: 35934857 No abstract available.

2

Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia.

Dahl E, Gluud LL, Kimer N, Krag A. Dahl E, et al. Among authors: kimer n. Aliment Pharmacol Ther. 2012 Oct;36(7):619-26. doi: 10.1111/apt.12025. Epub 2012 Aug 21. Aliment Pharmacol Ther. 2012. PMID: 22908905 Free article.

3

Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials.

Kimer N, Dahl EK, Gluud LL, Krag A. Kimer N, et al. BMJ Open. 2012 Oct 22;2(5):e001313. doi: 10.1136/bmjopen-2012-001313. Print 2012. BMJ Open. 2012. PMID: 23089208 Free PMC article.

4

New vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory state.

Kimer N, Goetze JP, Bendtsen F, Møller S. Kimer N, et al. Eur J Clin Invest. 2014 May;44(5):441-52. doi: 10.1111/eci.12249. Epub 2014 Feb 26. Eur J Clin Invest. 2014. PMID: 24476551

5

Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy.

Kimer N, Krag A, Gluud LL. Kimer N, et al. Patient Prefer Adherence. 2014 Mar 18;8:331-8. doi: 10.2147/PPA.S41565. eCollection 2014. Patient Prefer Adherence. 2014. PMID: 24672227 Free PMC article. Review.

6

Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy.

Kimer N, Krag A, Møller S, Bendtsen F, Gluud LL. Kimer N, et al. Aliment Pharmacol Ther. 2014 Jul;40(2):123-32. doi: 10.1111/apt.12803. Epub 2014 May 21. Aliment Pharmacol Ther. 2014. PMID: 24849268 Free article. Review.

7

Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature.

Kimer N, Feineis M, Møller S, Bendtsen F. Kimer N, et al. Scand J Gastroenterol. 2015 Feb;50(2):129-37. doi: 10.3109/00365521.2014.948053. Epub 2014 Aug 12. Scand J Gastroenterol. 2015. PMID: 25113796 Review.

8

Letter: the effects of rifaximin in hepatic encephalopathy--authors' reply.

Kimer N, Krag A, Gluud LL. Kimer N, et al. Aliment Pharmacol Ther. 2014 Oct;40(7):858-9. doi: 10.1111/apt.12904. Aliment Pharmacol Ther. 2014. PMID: 25185737 Free article. No abstract available.

9

Advances in the treatment of portal hypertension in cirrhosis.

Kimer N, Wiese S, Mo S, Møller S, Bendtsen F. Kimer N, et al. Expert Rev Gastroenterol Hepatol. 2016 Aug;10(8):961-9. doi: 10.1586/17474124.2016.1166952. Epub 2016 Mar 28. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26982499 Review.

10

Research update for articles published in EJCI in 2014.

Agra RM, Al-Daghri NM, Badimon L, Bodi V, Carbone F, Chen M, Cubedo J, Dullaart RP, Eiras S, García-Monzón C, Gary T, Gnoni A, González-Rodríguez Á, Gremmel T, Hafner F, Hakala T, Huang B, Ickmans K, Irace C, Kholová I, Kimer N, Kytö V, März W, Miazgowski T, Møller S, Montecucco F, Niccoli G, Nijs J, Ozben S, Ozben T, Papassotiriou I, Papastamataki M, Reina-Couto M, Rios-Navarro C, Ritsch A, Sabico S, Seetho IW, Severino A, Sipilä J, Sousa T, Taszarek A, Taurino F, Tietge UJ, Tripolino C, Verloop W, Voskuil M, Wilding JP. Agra RM, et al. Among authors: kimer n. Eur J Clin Invest. 2016 Oct;46(10):880-94. doi: 10.1111/eci.12671. Eur J Clin Invest. 2016. PMID: 27571922 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page